Companies / Financials
TROW
T. Rowe Price
Asset Management & Custody Banks
Asset Management & Custody BanksAnalysis in progress
In progress
We are decoding this company's strategy and relationships
New analyses are published every weekday. Founding members get them first.
Business at a glance
Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work
Operating health70
Growth37
Profitability92
Cash generationn/a
Balance sheetn/a
Dilution control82
Key ratios and five-year financials
Latest quarter revenue YoY (2026-09-30)5.9%Revenue growth (FY)3.1%Revenue CAGR (3y)4.1%Gross margin—Operating margin29.9%Net margin28.5%Free cash flow margin20.2%R&D / revenue—Stock comp / revenue3.0%Net debt / operating cash flow—Current ratio—Diluted share count change-1.3%
| Fiscal year ending | FY 2021-12 | FY 2022-12 | FY 2023-12 | FY 2024-12 | FY 2025-12 |
|---|---|---|---|---|---|
| Revenue | $7.7B | $6.5B | $6.5B | $7.1B | $7.3B |
| Operating income | $3.7B | $2.4B | $2.0B | $2.3B | $2.2B |
| Net income | $3.1B | $1.6B | $1.8B | $2.1B | $2.1B |
| Operating cash flow | $3.5B | $2.4B | $1.2B | $1.7B | $1.8B |
| Capital expenditure | $239M | $238M | $308M | $423M | $274M |
| Free cash flow | $3.2B | $2.1B | $911M | $1.3B | $1.5B |
| Stock-based comp | $275M | $285M | $266M | $247M | $217M |
| Buybacks | $1.1B | $850M | $254M | $337M | $621M |
| Dividends | $1.7B | $1.1B | $1.1B | $1.1B | $1.1B |
| Cash | $1.5B | $1.8B | $2.1B | $2.6B | $3.4B |
| Equity | $9.0B | $8.8B | $9.5B | $10.3B | $10.9B |
StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.